Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

Daily news and press releases about Healthcare

older | 1 | .... | 1068 | 1069 | (Page 1070) | 1071 | 1072 | .... | 1118 | newer

    0 0

    (EMAILWIRE.COM, August 10, 2018 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Statutory First Aid Kits Sales in these regions, from 2013 to 2025 (forecast), covering
    • North America
    • Europe
    • China
    • Japan
    • Southeast Asia
    • India
    Access Report Details at: https://www.themarketreports.com/report/global-statutory-first-aid-kits-sales-market-report-2018

    Global Statutory First Aid Kits Sales market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    • Acme United
    • Johnson & Johnson
    • 3m
    • Zee
    • Certified Safety
    • Cintas
    • Rei
    • Lifeline
    • Honeywell
    • Tender
    • St John
    • Hartmann
    • Safety First Aid
    • Lifesystems
    • First Aid Holdings
    • Firstar
    • Kanglidi Medical
    • Yunnan Baiyao
    Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/948655

    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    • Common Type
    • Special Type
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Statutory First Aid Kits Sales for each application, including
    • Transportation
    • Sports
    • House & Office Hold
    • Outdoor
    • Industrial & Manufacturing Facilities
    • Military
    • Other
    Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/948655.


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, August 10, 2018 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Stem Cell Banking Sales in these regions, from 2013 to 2025 (forecast), covering
    • North America
    • Europe
    • China
    • Japan
    • Southeast Asia
    • India
    Access Report Details at: https://www.themarketreports.com/report/global-stem-cell-banking-sales-market-report-2018

    Global Stem Cell Banking Sales market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    • Ccbc
    • Cbr
    • Viacord
    • Esperite
    • Vcanbio
    • Boyalife
    • Lifecell
    • Crioestaminal
    • Rms Regrow
    • Cordlife Group
    • Pbkm Famicord
    • Cells4life
    • Beikebiotech
    • Stemcyte
    • Cryo-Cell
    • Cellsafe Biotech Group
    • Pacificord
    • Americord
    • Krio
    • Familycord
    • Cryo Stemcell
    • Stemade Biotech
    Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/942951

    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    • Umbilical Cord Blood Stem Cell
    • Embryonic Stem Cell
    • Adult Stem Cell
    • Other
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Stem Cell Banking Sales for each application, including
    • Diseases Therapy
    • Healthcare
    Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/942951


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, August 10, 2018 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Sternum Saw Blades Sales in these regions, from 2013 to 2025 (forecast), covering
    • North America
    • Europe
    • China
    • Japan
    • Southeast Asia
    • India
    Access Report Details at: https://www.themarketreports.com/report/global-sternum-saw-blades-sales-market-report-2018

    Global Sternum Saw Blades Sales market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    • Busa Surgical Instrumentation
    • Stryker
    • Brasseler Usa
    • Linvatec
    • Cardinal Health
    • Terumo Cardiovascular Group
    • Microaire Sugical
    Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/933658

    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    • Hard Alloy Saw Blades
    • High Speed Steel Saw Blades
    • Acrylic Saw Blades
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Sternum Saw Blades Sales for each application, including
    • Hospital
    • Clinic
    • Other
    Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/933658


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, August 10, 2018 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Sternum Saws Sales in these regions, from 2013 to 2025 (forecast), covering
    • North America
    • Europe
    • China
    • Japan
    • Southeast Asia
    • India
    Access Report Details at: https://www.themarketreports.com/report/global-sternum-saws-sales-market-report-2018

    Global Sternum Saws Sales market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    • Stryker
    • Conmed
    • Smith & Nephew
    • Sternum Saws
    • Medtronic
    • Terumo Cardiovascular
    • Aesculap USA
    • Cardinal Health
    • Noromedikal
    • Demir Medikal
    • FREUND
    • Arthrex
    • MicroAire Surgical Instruments
    Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/933659

    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    • Battery Powered Sternum Saws
    • Electric Powered Sternum Saws
    • Pneumatic Powered Sternum Saws
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Sternum Saws Sales for each application, including
    • Hospital
    • Clinic
    • Other
    Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/933659


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, August 20, 2018 ) Industry Outlook and Trend Analysis

    The Enteral Feeding Devices Market was worth USD 1.71 billion in the year of 2012 and is expected to reach approximately USD 2.98 billion by 2022, while registering itself at a compound annual growth rate (CAGR) of 5.11% during the forecast period. Enteral feeding alludes to the conveyance of nutrients specifically to the stomach by means of the utilization of a feeding tube. Enteral feeding is provided to patients who can't eat regularly attributable to diseases, for example, gastrointestinal injuries, oral cancer, and disorders and so on. The developing worldwide aged populace base and developing predominance of ceaseless sicknesses, for example, diabetes, extreme pancreatitis, and other gastrointestinal ailments and expanding frequencies of preterm births are certain aspects that are anticipated to boost market development throughout the following years. Ageing increases a patient's weakness towards Parkinson's disease and different nervous issue. Moreover, the developing pervasiveness of individuals with diabetes mellitus requiring enteral nourishment is relied upon to positively affect the market. In 2013 the worldwide enteral feeding devices market was esteemed at USD 1,813.7 million and is relied upon to develop at a significant pace amid the gauge time frame. Neglected medical requirements in developing markets, for example, China, India and Brazil and the advent of new items empowered with mechanical progressions are required to serve this market as future development opportunities.

    Request Sample Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-CMR-HnM-54910

    Product Outlook and Trend Analysis

    The global enteral feeding devices market is arranged into six product sections in particular giving sets, gastrostomy tubes, percutaneous endoscopic gastrostomy devices, enteral feeding pumps, nasogastric tubes and low profile gastrostomy devices. The enteral nourishing pump commanded the market on the basis of share in 2013 at more than 60 percent significantly by virtue of its high use rates in created locales, for example, North America and Western Europe. Additionally, the enteral feeding pumps portion was trailed by nasogastric tubes in terms of profit and its worldwide market was esteemed at USD 196.6 million in 2013. These tubes are utilized in medical methods called nasogastric tubation, which includes the utilization of a tube for feeding or nutrition by means of the nasal course.

    Regional Outlook and Trend Analysis

    Major regions represented in this study incorporate Asia-Pacific, Europe, North America and RoW. Europe held the biggest share of the market in 2013 at roughly 35 percent. The existence of a vast aged populace base particularly in the Western European district, developing commonness of pre-term births and the advent of industry-friendly directions, for example, the execution of ISO models for small bore connectors are a portion of the key drivers of this market. In any case, the Asia-Pacific enteral feeding devices market is relied upon to develop at a significant pace attributable to drivers, for example, the existence of high neglected medicinal requirements in developing markets with continually enhancing healthcare framework and human services uses, for example, India and China. Likewise, the existence of a substantial aged populace base in Japan is anticipated to bolster the demand for enteral feeding devices in this area.

    Competitive Insights

    The worldwide enteral feeding devices market is oligopolistic in nature with four noteworthy players namely Danone, Abbott Nutrition, Fresenius and Nestle representing a share more than 75 percent of the total revenue. Enhancement of products, advancements in technology and penetration into the developing markets of Latin America and Asia with the aim to capitalize on undiscovered opportunities are major strategies for growth implemented by market players. The market was dominated by Abbott Nutrition in 2013 with a share of more than 30 percent. Some of the other prominent players in the market are Boston Scientific, CONMED Corporation, Amsino International Inc, Kimberly Clark Hygiene Products Pvt Ltd, Cook Medical and Moog Inc.

    Enquiry About Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-CMR-HnM-54910

    The global Enteral Feeding Devices Market is segmented as follows :

    By Product:

    Giving Sets
    Percutaneous Endoscopic Gastronomy Device
    Enteral Feeding Pump
    Nasogastric Tube
    Low Profile Gastrostomy Device
    Gastrostomy Tube

    By Region

    North America
    U.S
    Canada
    Mexico

    Europe
    Germany
    France
    UK
    Italy
    Spain
    Rest of Europe

    Asia-Pacific
    Japan
    China
    Australia
    India
    South Korea
    Rest of Asia Pacific

    Rest of the World
    Brazil
    South Africa
    Saudi Arabia
    United Arab Emirates
    Others

    Some of the key questions answered by the report are:

    What was the market size in 2012 and forecast from 2013 to 2022?
    What will be the industry market growth from 2013 to 2022?
    What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
    What are the major segments leading the market growth and why?
    Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

    Get Discount@ https://www.qurateresearch.com/report/discount/HnM/QBI-CMR-HnM-54910



    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, August 21, 2018 ) Caspase 9 Market (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) - Caspase-9 is an initiator caspase encoded by the CASP9 gene. Binding of caspase-9 to Apaf-1 leads to activation of the protease which cleaves and activates caspase-3. It is involved in the activation cascade of caspases market responsible for apoptosis execution. It promotes DNA damage-induced apoptosis in an ABL1/c-Abl-dependent manner.

    Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) pipeline Target constitutes close to 7 molecules. Out of which approximately 5 molecules are developed by companies and remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II and Preclinical stages are 1, 2 and 2 respectively.

    Request a sample of Caspase 9 Pipeline Market research report @ rnhttps://www.reportsnreports.com/contacts/requestsample.aspx?name=1608700

    Similarly, the universities portfolio in Preclinical and Discovery stages comprises 1 and 1 molecules, respectively. Report covers products from therapy areas Oncology, Immunology, Cardiovascular, Gastrointestinal, Genito Urinary System And Sex Hormones, Hematological Disorders, Infectious Disease, Metabolic Disorders, Ophthalmology and Toxicology which include indications Age Related Macular Degeneration, Autoimmune Hepatitis, Bladder Cancer, Chemotherapy Induced Neutropenia, Colorectal Cancer, Diabetic Retinopathy, Febrile Neutropenia, Glioblastoma Multiforme (GBM), Graft Versus Host Disease (GVHD), Hepatitis C, Liver Cirrhosis, Liver Failure (Hepatic Insufficiency), Liver Fibrosis, Liver Transplant Rejection, Metastatic Brain Tumor, Metastatic Breast Cancer, Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer, Metastatic Pancreatic Cancer, Multiple Myeloma (Kahler Disease), Non Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic Steatohepatitis (NASH), Non-Small Cell Lung Cancer, Pancreatic Islet Transplant Rejection, Portal Hypertension, Prostate Cancer, Renal Failure, Small-Cell Lung Cancer and Solid Tumor.

    Download PDF of Caspase 9 Pipeline Market research report @ rnhttps://www.reportsnreports.com/contacts/requestsample.aspx?name=1608700

    The latest report Caspase 9 - Pipeline Review, H2 2018, outlays comprehensive information on the Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) targeted therapeutics development with respective active and dormant or discontinued projects.

    The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

    Inquire for discount on Caspase 9 Pipeline Market research report @ rnhttps://www.reportsnreports.com/contacts/discount.aspx?name=1608700

    Scope
    - The report provides a snapshot of the global therapeutic landscape for Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62)
    - The report reviews Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
    - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
    - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
    - The report reviews key players involved in Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) targeted therapeutics and enlists all their major and minor projects
    - The report assesses Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
    - The report summarizes all the dormant and discontinued pipeline projects
    - The report reviews latest news and deals related to Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) targeted therapeutics

    Get a copy of Caspase 9 Pipeline Market research report @ rnhttps://www.reportsnreports.com/purchase.aspx?name=1608700

    Reasons to buy
    - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
    - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
    - Identify and understand the targeted therapy areas and indications for Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62)
    - Identify the use of drugs for target identification and drug repurposing
    - Identify potential new clients or partners in the target demographic
    - Develop strategic initiatives by understanding the focus areas of leading companies
    - Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
    - Devise corrective measures for pipeline projects by understanding Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) development landscape
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

    About Us:
    ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. Feel free to Call us at + 1 888 391 5441 or Email us at sales@reportsandreports.com



    Ganesh Pardeshi
    + 1 888 391 5441
    sales@reportsandreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, August 20, 2018 ) Industry Outlook and Trend Analysis

    The Breast Biopsy Device Market was worth USD 0.38 billion in the year 2012 and is expected to reach approximately USD 1.03 billion by 2022, while registering itself at a significant compound annual growth rate (CAGR) of 9.39% during the forecast period. It is a diagnostic method that includes the expulsion of fluid or tissue from a suspicious region. The test needs working with guidance systems, the intent behind which is to detect an abnormality or a lump from the breast area. The varied modalities utilized as controlling systems in the location of breast tumors incorporate the ultrasound, mammography, and magnetic resonance imaging. The ultrasound section is foreseen to witness the quickest development attributable to the increasing requirement of non-radiation biopsies alongside the increasing interest for minimally invasive techniques. The expansion in the recurrence of breast cancers in women worldwide, and in addition the ascent in awareness of cancer screening programs is a portion of the components that are assessed to add to the market development over the gauged time frame. Furthermore, the various kinds of product improvement, ceaselessly propelled in the market are additionally anticipated that would positively affect this industry amid the estimated time frame. For example, C.R Bard's Mission Truguide disposable coaxial biopsy needles, made of ultrathin walls, give high effectiveness and precision in the securing of sample tissue. Nonetheless, the dangers engaged with the methodology are probably going to influence the Breast Biopsy Device Market contrarily. The level of hazard considers the invasiveness of the method utilized. Surgical core methods may be more precise and successful however it includes real dangers. Besides, roughly 60%to 80% of the biopsies acquired are generous. Subsequently, women are urged to take a second opinion before experiencing any such surgical strategies, which thusly is relied upon to contrarily influence the market development.

    Get Free Sample Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-CMR-HnM-54912

    Procedure Type Outlook and Trend Analysis

    Based on the type of the procedure, this market industry is categorized into open surgical and needle breast biopsies. The latter is additionally classified into core-needle biopsy, fine-needle biopsy and vacuum-assisted Biopsy. Owing to the ascending demand for minimally invasive procedures, in 2015 the fine-needle aspiration segment was accountable for a greater marker share. Fine-needle aspiration biopsy is the simplest form of breast biopsy done and mostly performed to rule out lump which can be felt at the time of clinical breast exam. The procedure involves thin needle (with syringe) being directly injected into the lump to collect cell samples. On the other hand, due to the less-invasive nature of the procedure, the vacuum-assisted core biopsy is expected to bud at a considerable higher CAGR during the forecast period. The procedure involves a minor incision through which the needle is injected, following which the sample is collected with the help of a vacuum-powered device. Also, core-needle biopsy is gradually being performed more as a breast biopsy and is anticipated to stay predominant sub-segment as compared to others. Owing to the invasiveness of open surgical breast biopsy, which are of two types, i.e., incisional and excisional breast biopsies, these procedures are less preferred unless in extreme cases. Incisional biopsy extracts a particular part from the suspicious area which is sufficient for diagnosis. Whereas, excisional biopsy removes complete part of the abnormal, tumor area, either with or without taking an edge of the normal breast tissue.

    Product Outlook and Trend Analysis

    The key products utilized for breast biopsy are guidance systems, localization wires, biopsy tables and needles among others. In 2015, the needles segment possessed a major share. This development is accountable to its wide relevance in the needle breast biopsy market. A large portion of the developments and progressions are seen in the products section. For example, the Stryker PreciseCore needle lets sample collection with higher accuracy and with far less risks of tissue damage included. Moreover, the guidance system product section is foreseen to witness a high development rate amid the projected time frame. In needles, the fine needle aspiration makes use of a very small needle to remove cells or liquid from the abnormal part and the core needle make the use of a big hollow needle to extract one sample of the breast in every insertion. In localization wires a guide wire is put into the suspicious part to assist the surgeon to detect the lesion for surgical biopsy.

    Guidance Type Outlook and Trend Analysis

    The biopsy methods require guidance systems to find the irregularity or lumps in the breast area. The accessible guiding systems utilized for biopsies incorporate the magnetic resonance guided biopsies, ultrasound-guided, and mammography-guided stereotactic among others that guide with the technique in identifying and finding the existence of unusual cell developments. The mammography-guided portion adds to the biggest share in the industry. Nonetheless, the likelihood of false positive outcomes related with the imaging of breast tissues that are dense is generally high. The ultrasound-guided method yields more exact outcomes and is foreseen to witness the most striking development rate amid the forecast period.

    Regional Outlook and Trend Analysis

    North America is accountable for a bigger market share, primarily due to existence of key market players and prompts adoption of enhanced medical technologies, especially in countries like Canada and the U.S. According to a non-profit organization which emphasizes on breast cancer awareness – Susang Komen, in 2015 there were more than 2.3 million breast cancer cases that were diagnosed in the United States alone. Asia Pacific region is anticipated to gain lucrative market during the forecast period. This is due to the increased level of awareness amongst the population, rising disposable income, and large population. International Association of Cancer Registries stated that in 2012, more than 600,000 fresh cases of breast cancer were diagnosed in Asia and that accounted for 39% of overall breast cancers diagnosed across the world. In EU-28 of The European Breast Cancer Coalition, it has been stated that in 2012, 361,600 breast cancer cases were registered. Also, one in every eight women in the EU-28 is expected to acquire breast cancer before the age of 85.

    Competitive Insights

    Some major players in the market are Devicor Medicals Products, Inc, C. R. Bard, Inc., OncoCyte Corporation, Stryker International, Inc., Dickinson and Company (BD), F. Hoffmann-La Roche Ltd., Hologic Inc, and Laboratory Corporation of America Holdings (Labcorp). These organizations are extensively inclined in the enhancement of new products, decreasing the cost of production and in implementing strategies like approvals from the Food and Drug Administration, acquisitions and mergers in order to upkeep their position in the industry. For example, Hologic, Inc declared its approval from the Food and Drug Administration for the Affirm Prone biopsy system that is commercially available. The new product is a guided system that is equipped with 2D/3D imaging characteristics.

    Enquiry About Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-CMR-HnM-54912

    The global Breast Biopsy Devices market is segmented as follows:

    By Procedure Type

    Needle Breast Biopsy
    Core-needle Biopsy
    Fine-needle Aspiration Biopsy
    Vacuum-assisted Biopsy

    Open Surgical Breast Biopsy
    Excisional Breast Biopsy
    Incisional Breast Biopsy

    By Product

    Guidance Systems
    Biopsy Tables
    Localization Wires
    Biopsy Needles
    Others (Punches, Markers, Sutures)

    By Guidance Type

    Ultrasound-guided Breast Biopsy
    Mammography-guided Stereotactic Breast Biopsy
    Magnetic Resonance-guided Breast Biopsy
    Others (thermography, PET)

    By Region

    North America
    U.S
    Canada
    Mexico

    Europe
    Germany
    France
    UK
    Italy
    Spain
    Rest of Europe

    Asia-Pacific
    Japan
    China
    Australia
    India
    South Korea
    Rest of Asia Pacific

    Rest of the World
    Brazil
    South Africa
    Saudi Arabia
    United Arab Emirates
    Others

    Some of the key questions answered by the report are:

    What was the market size in 2012 and forecast from 2013 to 2022?
    What will be the industry market growth from 2013 to 2022?
    What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
    What are the major segments leading the market growth and why?
    Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

    Get Discount@ https://www.qurateresearch.com/report/discount/HnM/QBI-CMR-HnM-54912



    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, August 21, 2018 ) Browse 199 market data Tables and 39 Figures spread through 280 Pages and in-depth TOC on "IoT Medical Devices Market - Global Forecast to 2023"
    https://www.marketsandmarkets.com/Market-Reports/iot-medical-device-market-15629287.html

    By type, the wearable medical devices segment is expected to grow at the highest CAGR during the forecast period

    On the basis of type, the IoT Medical Devices Market is categorized into stationary medical devices, implantable medical devices, and stationary medical devices. The wearable medical devices segment is expected to grow at the highest CAGR due to increasing health awareness, preference for preventive care, rising need for the prolonged home health monitoring of patients owing to the rising geriatric population, and subsequent prevalence of chronic diseases are making wearable devices common in home care settings.

    By type of vital signs monitoring devices, the blood glucose monitoring devices segment is expected to have the largest market share

    On the basis of type, the vital signs monitoring market is categorized into blood pressure monitors, blood glucose monitors, ECG/heart rate monitors, oximeters, and multiparameter monitors. The blood glucose monitoring devices segment held the largest market share in 2017. The increasing adoption of smartphones and changing lifestyles have boosted market momentum in favor of IoT-enabled wearable glucose monitoring device since companion software (device-linked applications) enables vital data transfer to physicians for better diagnosis.

    Download FREE Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=15629287

    By end user, the nursing homes, assisted living facilities, long-term care centers, & home care settings segment is expected to grow at the fastest CAGR during the forecast period

    The major end users of IoT medical devices market are hospitals & clinics, nursing homes, assisted living facilities, long-term care centers, & home care settings, and other end users. The nursing homes, assisted living facilities, long-term care centers, & home care settings segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of this market segment is attributed to the need for prolonged treatment for certain chronic diseases, increasing preference for participatory and preventive care by patients, high cost of hospital stays, and the growing number of nursing homes, assisted living facilities, and long-term care centers. The increasing inclination towards self-health management has also propelled the use of IoT-enabled medical devices for patient monitoring.

    APAC is expected to grow at the highest CAGR during the forecast period

    APAC is expected to grow at the highest CAGR during the forecast period. Asia Pacific countries, particularly China and India, offer significant growth opportunities for players in the market owing to the growing government initiatives for the promotion of eHealth, rising medical tourism, growing awareness among patients about self-health management, and the growing demand for quality healthcare.

    GE Healthcare (US), Philips (Netherlands), Medtronic (US), Honeywell Life Care Solutions (US), BIOTRONIK Germany), Boston Scientific (US), Johnson & Johnson (US), Siemens (Germany), Omron (Japan), BioTelemetry (US), AliveCor (US), iHealth Lab (US), AgaMatrix (US), Abbott Laboratories (US), STANLEY Healthcare (US), and Welch Allyn (US) are the prominent players operating in the IoT medical devices market. Product launches, product upgradations, and approvals are the major organic growth strategies undertaken by these players. The companies are also focused on inorganic growth strategies like acquisitions, collaborations, and partnerships with other medical technology companies as well as digital technology and software companies to strengthen their IoT device product portfolio as well as garner a larger share in the market.

    Press Release: https://www.marketsandmarkets.com/PressReleases/iot-medical-device.asp

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:
    Mr. Shelly Singh
    MarketsandMarkets™ INC. 
    630 Dundee Road 
    Suite 430 
    Northbrook, IL 60062 
    USA : 1-888-600-6441 
    sales@marketsandmarkets.com


    Ganesh Pardeshi
    +91 9890103464
    ganesh.pardeshi@reportsandreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, August 20, 2018 ) The Global 3D Orthopedic Scanning System Market 2018 to 2025 renders deep perception of the key regional market status of the 3D Orthopedic Scanning System Industry on a global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, China and Japan.

    The report on “Global 3D Orthopedic Scanning System Market” is a professional report which provides thorough knowledge along with complete information pertaining to the 3D Orthopedic Scanning System industry a propos classifications, definitions, applications, industry chain summary, industry policies in addition to plans, product specifications, manufacturing processes, cost structures, etc.

    The major manufacturers covered in this report

    • Elinvision

    • Artec Europe

    • Orthopaedic Innovation Centre

    • Fuel 3D Technologies Limited

    • TechMed 3D Inc

    • FARO Technologies

    • 3D Systems

    • SCANNY3D S.R.L

    • AGE Solutions S.r.l.

    Get Sample Copy of this Report @ https://www.qyresearchgroups.com/request-sample/1001499

    On the basis of product, primarily split into

    • Scanning system

    • Software

    • Accessories

    On the basis of the end users/applications

    • Spine

    • Dental

    • Maxillofacial

    • Cosmetic Surgeries

    • Others

    The potential of this industry segment has been rigorously investigated in conjunction with primary market challenges. The present market condition and future prospects of the segment has also been examined. Moreover, key strategies in the market that includes product developments, partnerships, mergers and acquisitions, etc., are discussed. Besides, upstream raw materials and equipment and downstream demand analysis is also conducted.

    Check Discount @ https://www.qyresearchgroups.com/check-discount/1001499

    Report Includes:-
    The report cloaks the market analysis and projection of “3D Orthopedic Scanning System Market” on a regional as well as global level. The report constitutes qualitative and quantitative valuation by industry analysts, first-hand data, assistance from industry experts along with their most recent verbatim and each industry manufacturers via the market value chain.

    The research experts have additionally assessed the in general sales and revenue generation of this particular market. In addition, this report also delivers widespread analysis of root market trends, several governing elements and macro-economic indicators, coupled with market improvements as per every segment.

    Major Points Covered in Table of Contents –

    1 3D Orthopedic Scanning System Market Overview

    2 Global 3D Orthopedic Scanning System Market Competition by Manufacturers

    3 Global 3D Orthopedic Scanning System Capacity, Production, Revenue (Value) by Region (2013-2018)

    4 Global 3D Orthopedic Scanning System Supply (Production), Consumption, Export, Import by Region (2013-2018)

    5 Global 3D Orthopedic Scanning System Production, Revenue (Value), Price Trend by Type

    6 Global 3D Orthopedic Scanning System Market Analysis by Application

    7 Global 3D Orthopedic Scanning System Manufacturers Profiles/Analysis

    8 3D Orthopedic Scanning System Manufacturing Cost Analysis

    9 Industrial Chain, Sourcing Strategy and Downstream Buyers

    10 Marketing Strategy Analysis, Distributors/Traders

    11 Market Effect Factors Analysis

    12 Global 3D Orthopedic Scanning System Market Forecast (2018-2025)

    13 Research Findings and Conclusion

    14 Appendix

    Make An Enquiry @ https://www.qyresearchgroups.com/send-an-enquiry/1001499

    About Us:

    QY Research Groups is a company that simplifies how analysts and decision makers get industry data for their business. Our unique colossal technology has been developed to offer refined search capabilities designed to exploit the long tail of free market research whilst eliminating irrelevant results. QY Research Groups is the collection of market intelligence products and services on the Web. We offer reports and update our collection daily to provide you with instant online access to the world's most complete and current database of expert insights on global industries, companies, products, and trends.



    Zhang Wei
    +1-888-236-2744
    zhang@qyresearchgroups.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, August 20, 2018 ) In the year 2018, Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market was valued at USD 10.46 Billion. By the year 2023, it is predicted to reach USD 16.09 Billion with pace of 9.00% CAGR. Among children and adults Attention deficit hyperactivity disorder (ADHD) is a psychiatric/neurological disorder. It is common in children below 12 years when compared to adults. ADHD is also known as neuropsychiatric disorder or hyperkinetic disorder/ attention deficit disorder. There is no concrete evidence with respect to the exact cause of ADHD disorder. But it is said to be caused by genetic factors and environmental influences. Symptoms of the disease include lack of concentration, impatience, distraction and difficulty in remembering things. ADHD can be controlled by medication, education/training and psychotherapy.

    Request Report Sample: https://www.marketdataforecast.com/market-reports/attention-deficit-hyperactivity-disorder-therapeutics-market-304/request-sample

    Increasing awareness about mental illness and advancements in the medical field
    Factors affecting market growth:
    • Increasing awareness among people about psychological disorders. (+)
    • Increasing advancements in medical field. (+)
    • Concentration of biotechnology and pharmaceutical companies to develop effective therapeutics. (+)
    • Expensive prices of ADHD medications. (-)
    • Side effects such as insomnia, dizziness, headaches and mood swings.

    Get your customized report: https://www.marketdataforecast.com/market-reports/attention-deficit-hyperactivity-disorder-therapeutics-market-304/customize-report

    North America holds the major share of Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market.
    Market Segmentation
    Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market is geographically segmented into
    • North America.
    • Europe.
    • Asia Pacific.
    • Latin America.
    • Middle East and Africa.
    North America topped the list with 36% of Attention Deficit Hyperactivity Disorder market in 2018. In addition, Asia Pacific region is estimated grow faster at highest CAGR of 12.30% during forecasted period of 2018-2023. The market is expected to grow due to increased disposable incomes and presence of economically evolving regions.

    Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/attention-deficit-hyperactivity-disorder-therapeutics-market-304/

    Key players:
    Key players competing in the Global Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market include Curemark, LLC. (U.S.), Johnson & Johnson (U.S.), Novartis AG (Switzerland), Noven Pharmaceuticals, Inc. (U.S.), Supernus Pharmaceuticals, Inc. (U.S.), Alcobra Ltd. (Israel), Pfizer Inc. (U.S.), Eli Lilly and Company (U.S.), Neos Therapeutics, Inc. (U.S.), and Shire plc (Ireland).

    Contact Info:
    Name: Mr. Abhishek Shukla
    Email: abhishek@marketdataforecast.com
    Organization: MarketDataForecast™
    Address: 2nd Floor, Above ICICI Bank,B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
    Phone: +1-888-702-9626



    Abhishek Shukla
    +1-888-702-9626
    abhishek@marketdataforecast.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, August 20, 2018 )
    The Lung Cancer Diagnostic Tests Industry is expected to increase at high growth rates during the forecast period (2018-2023). The Lung Cancer Diagnostic Tests Industry is supported by various growth drivers. Lung cancer screening refers to cancer screening strategies used to identify early lung cancers before they cause symptoms, at a point where they are more likely to be curable.

    Download free sample at https://www.researchreportsinc.com/sample-request?id=66755

    There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023.

    This report covers following regions:
    *North America
    *South America
    *Asia & Pacific
    *Europe
    *MEA (Middle East and Africa)

    Ask for customization at https://researchreportsinc.com/enquiry?id=66755

    The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
    For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.
    For competitor segment, the report includes global key players as well as some small players.

    The companies include:
    Advpharma Inc, AIT Austrian Institute of Technology GmbH, Courtagen Life Sciences Inc, DiagnoCure Inc. (Inactive), BioMark Diagnostics Inc., BioMarker Strategies LLC, Emory University, Epigenomics AG, et al.

    Ask for discount at https://www.researchreportsinc.com/check-discount?id=66755

    Table of contents
    Chapter 1: Executive Summary
    Chapter 2: Abbreviation and Acronyms
    Chapter 3: Preface
    Chapter 4: Market Landscape
    Chapter 5: Market Trend Analysis
    Chapter 6: Industry Chain Analysis
    Chapter 7: Latest Market Dynamics
    Chapter 8: Trading Analysis
    Chapter 9: Historical and Current Lung Cancer Diagnostic Tests Industry Market in North America (2013-2018)
    Chapter 10: Historical and Current Lung Cancer Diagnostic Tests Industry Market in South America (2013-2018)
    Chapter 11: Historical and Current Lung Cancer Diagnostic Tests Industry Market in Asia & Pacific (2013-2018)
    Chapter 12: Historical and Current Lung Cancer Diagnostic Tests Industry Market in Europe (2013-2018)
    Chapter 13: Historical and Current Lung Cancer Diagnostic Tests Industry Market in MEA (2013-2018)
    Chapter 14: Summary for Lung Cancer Diagnostic Tests Industry Market (2013-2018)
    Chapter 15: Lung Cancer Diagnostic Tests Industry Market Forecast (2019-2023)
    Chapter 16: Company Profile
    16.1 Company
    16.1.1 Company Profile
    16.1.2 Main Business and Lung Cancer Diagnostic Tests Industry Information
    16.1.3 SWOT Analysis of Company A
    16.1.4 Company A Lung Cancer Diagnostic Tests Industry Sales, Revenue, Price and Gross Margin (2013-2018)

    Buy report at https://researchreportsinc.com/checkout/?add-to-cart=66755&&attribute_pa_choose-license=single-user&&quantity=1

    The information for each competitor includes:
    Company Profile
    Main Business Information
    SWOT Analysis
    Sales, Revenue, Price and Gross Margin
    Market Share

    Contact Us
    David,
    Sales Manager,
    US/Canada: +1-855-419-2424
    UK: +4403308087577
    Email: sales@reseasrchreportsinc.com






    Shubham Goel
    8554192424
    sales@researchreportsinc.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, August 21, 2018 ) Market Overview:
    Global Fluoroscopy Market values at USD 1990 Million in 2018 and it is expected to reach USD 22329.4 Millions with a CAGR of 3.2% by the end of 2023. Biopsy is the surgical removal of tissue from an organ to see the presence or extent of a disease, principally cancerous and inflammatory conditions. This diagnostic technique is mostly performed by surgeons, radiologists, and interventional cardiologists, to verify the presence of cancerous tissue. Biopsy procedures are often performed for almost any organ with the help of a specific biopsy device.
    Request Report Sample: https://www.marketdataforecast.com/market-reports/global-fluoroscopy-market-2066/request-sample
    Factors affecting market growth:
    • Growing population of Multipurpose imaging systems (+)
    • Use of Fluoroscopy in pain management (+)
    • It provides real time moving images of diagnostic evaluation of soft and hard tissues (+)
    • Growing number of government hospitals and qualifies interventionists (+)
    • Sophisticated medical facilities (-)
    • Radiation related risks (-)
    Get your customized report: https://www.marketdataforecast.com/market-reports/global-fluoroscopy-market-2066/customize-report
    Market Segmentation
    Global Fluoroscopy Market is segmented on the basis of

    Type
    • Fixed Systems
    • Mobile systems
    Applications
    • Biopsy
    • Medications
    • Cardiovascular
    • Orthopedic Surgeries
    • others
    End User
    • Clinics
    • Hospitals
    • Diagnostic Centers
    Mobile systems market accounted for the largest share of global fluoroscopy market. In application segment biopsy accounted the highest share. Laregest share highest growth of this segment can be attributed to the rising geriatric population.
    Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/global-fluoroscopy-market-2066/
    Key players:
    The major companies GE Healthcare., Orthoscan Inc., Hologic Inc., Shimadzu Corporation, Siemens Medical Solutions, Philips N.V., Hitachi Ltd., Toshiba Medical Systems Corporation, Ziehm Imaging GmbH, Amico X-ray innovations.

    Contact Info:
    Name: Mr. Abhishek Shukla
    Email: abhishek@marketdataforecast.com
    Organization: MarketDataForecast™
    Address: 2nd Floor, Above ICICI Bank,B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
    Phone: +1-888-702-9626



    Abhishek Shukla
    +1-888-702-9626
    abhishek@marketdataforecast.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, August 20, 2018 ) In the year 2018, Global Diabetic Retinopathy Market was valued at USD 6.97 Billion. By the year 2023, it is predicted to reach USD 9.73 Billion with pace of 6.9% CAGR. Diabetes is a long-lasting disease which causes abnormalities in the discharge of insulin from the pancreas or hyperglycaemia related to insulin level fluctuation, which in the end prompts long haul multi-organ complexities of nerves, heart, veins, kidneys, and eyes. Diabetes eventually damages blood vessels in the retina of eyes which may result in partial or complete blindness. The treatment for these complications depends on the various stages of diabetic retinopathy.

    Request Report Sample: https://www.marketdataforecast.com/market-reports/global-diabetic-retinopathy-market-936/request-sample

    Increasing cases of diabetes and patient’s awareness towards the specific complications are expected to drive the market.
    Factors affecting market growth:
    • Increasing risk of blindness due to diabetes. (+)
    • Increase in global geriatric population. (+)
    • Early detection of diabetic retinopathy. (+)
    • Increasing demand for the treatment of diabetic retinopathy. (+)
    • Lack of skilled ophthalmologists. (-)
    • Poor infrastructures and some strangest regulatory policies. (-)

    Get your customized report: https://www.marketdataforecast.com/market-reports/global-diabetic-retinopathy-market-936/customize-report

    North America holds the major share of Global Diabetic Retinopathy Market
    Market Segmentation
    The Global Diabetic Retinopathy is geographically segmented into
    • North America.
    • Europe.
    • Asia Pacific.
    • Latin America.
    • Middle East and Africa.
    North America holds the major share of the market due to population of obese people and increasing demand for the treatment. Europe region is trailing right behind North America in terms of market share. In addition, Asia Pacific region is anticipated to grow quicker with greater CAGR in forecasted period owing to emerging economies such as India and China, innovation in diagnostics and funding for diabetic patients.

    Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/global-diabetic-retinopathy-market-936/

    Key players:
    Key players competing actively in the Global Diabetic Retinopathy Industry include Ampio Pharmaceuticals Inc., Alimera Science Inc., Abbott Laboratories Inc., Valeant Pharmaceutical International Inc., Novartis AG, Regeneron Pharmaceutical Inc., Hoffmann-La Roche ltd, Pfizer Inc., and Ayer AG.

    Contact Info:
    Name: Mr. Abhishek Shukla
    Email: abhishek@marketdataforecast.com
    Organization: MarketDataForecast™
    Address: 2nd Floor, Above ICICI Bank,B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
    Phone: +1-888-702-9626



    Abhishek Shukla
    +1-888-702-9626
    abhishek@marketdataforecast.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, August 21, 2018 ) The Plant Sources Anti Cancer Agents Industry is expected to increase at high growth rates during the forecast period (2018-2023). The Plant Sources Anti Cancer Agents Industry is supported by various growth drivers. Plant sources of anti-cancer agents are plants, the derivatives of which have been shown to be usable for the treatment or prevention of cancer in humans.

    Download free sample at https://www.researchreportsinc.com/sample-request?id=67007

    Some plants that indicate potential as an anticancer agent in laboratory-based in vitro research – for example, Typhonium flagelliforme, and Murraya koenigii are currently being studied.
    There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023.

    This report covers following regions:
    *North America
    *South America
    *Asia & Pacific
    *Europe
    *MEA (Middle East and Africa)

    Ask for customization at https://researchreportsinc.com/enquiry?id=67007

    The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
    For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.
    For competitor segment, the report includes global key players as well as some small players.

    The companies include:
    Advpharma Inc, AIT Austrian Institute of Technology GmbH, Courtagen Life Sciences Inc, DiagnoCure Inc. (Inactive), BioMark Diagnostics Inc., BioMarker Strategies LLC, Emory University, Epigenomics AG, et al.

    Ask for discount at https://www.researchreportsinc.com/check-discount?id=67007

    Table of contents
    Chapter 1: Executive Summary
    Chapter 2: Abbreviation and Acronyms
    Chapter 3: Preface
    Chapter 4: Market Landscape
    Chapter 5: Market Trend Analysis
    Chapter 6: Industry Chain Analysis
    Chapter 7: Latest Market Dynamics
    Chapter 8: Trading Analysis
    Chapter 9: Historical and Current Plant Sources Anti Cancer Agents Industry Market in North America (2013-2018)
    Chapter 10: Historical and Current Plant Sources Anti Cancer Agents Industry Market in South America (2013-2018)
    Chapter 11: Historical and Current Plant Sources Anti Cancer Agents Industry Market in Asia & Pacific (2013-2018)
    Chapter 12: Historical and Current Plant Sources Anti Cancer Agents Industry Market in Europe (2013-2018)
    Chapter 13: Historical and Current Plant Sources Anti Cancer Agents Industry Market in MEA (2013-2018)
    Chapter 14: Summary for Plant Sources Anti Cancer Agents Industry Market (2013-2018)
    Chapter 15: Plant Sources Anti Cancer Agents Industry Market Forecast (2019-2023)
    Chapter 16: Company Profile
    16.1 Company
    16.1.1 Company Profile
    16.1.2 Main Business and Plant Sources Anti Cancer Agents Industry Information
    16.1.3 SWOT Analysis of Company A
    16.1.4 Company A Plant Sources Anti Cancer Agents Industry Sales, Revenue, Price and Gross Margin (2013-2018)

    Buy report at https://researchreportsinc.com/checkout/?add-to-cart=67007&&attribute_pa_choose-license=single-user&&quantity=1

    The information for each competitor includes:
    Company Profile
    Main Business Information
    SWOT Analysis
    Sales, Revenue, Price and Gross Margin
    Market Share

    Contact Us
    David,
    Sales Manager,
    US/Canada: +1-855-419-2424
    UK: +4403308087577
    Email: sales@reseasrchreportsinc.com



    Shubham Goel
    8554192424
    sales@researchreportsinc.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, August 21, 2018 ) In the year 2018, The Medical Holography Market was worth USD 436.16 million in 2018 and estimated to be growing at a CAGR of 31.3%, to reach USD 1702.04 million by 2023. Medical Holography allows medical professionals to ascertain a three-dimensional view of the interior of a patient. This allows doctors to diagnosis the vital organs in the body on a computer screen without having to cut through the body. Doctors can manipulate, view and dissect body parts which are recreated above a computer screen by using this technology. This has extremely high growth rate can be attributed to its productiveness in the medical field and has a lot of scope for growth since it’s a developing field.
    Request Report Sample: https://www.marketdataforecast.com/market-reports/medical-holography-market-3253/request-sample
    Growing number of cancer cases and technological advancements in the specific field are estimated to drive the market.
    Factors affecting market growth:
    • Rising adoption of holography in medical and biomedical research. (+)
    • The emergence of holography as a useful technology in representing abnormal 3D structures and growth in the applications of holography in the medical field. (+)
    • High price of equipment & computation of holographs and a few systems rendering imprecise holographs. (-)
    • Increasing disposable incomes and per capita incomes. (+)
    • High price of equipment & computation of holographs (-)

    Get your customized report: https://www.marketdataforecast.com/market-reports/medical-holography-market-3253/customize-report
    North America leads the Global Medical Holography market.
    Market Segmentation
    Global Medical Holography market is segmented on the basis of
    By Product
    • Holography Microscopes
    • Holoscopes
    • Holography Software
    By End users
    • Research Laboratories
    • Hospitals and Clinics
    • Academic Medical Centers
    • Pharmaceutical and Biotechnology Companies
    By Application
    • Medical Imagine
    • Biomedical Research and Medical Education
    Medical Imaging
    Biomedical Research and Medical Education

    Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/medical-holography-market-3253/
    Key players:
    The major shareholders of the Global Medical Holography market include NanoLive SA (Switzerland), Zebra Imaging (U.S.), zSpace, Inc. (U.S.), Holoxica Ltd. (U.K.), Ovizio Imaging systems (Belgium), Mach7 Technologies Pte. Ltd. (Australia), Realview Imaging Ltd. (Israel), Holografika Kft. (Hungary), Eon Reality (U.S.), Lyncee Tec (Switzerland), and EchoPixel, Inc. (U.S.).
    Contact Info:
    Name: Mr. Abhishek Shukla
    Email: abhishek@marketdataforecast.com
    Organization: MarketDataForecast™
    Address: 2nd Floor, Above ICICI Bank, B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
    Phone: +1-888-702-9626



    Abhishek Shukla
    +1-888-702-9626
    abhishek@marketdataforecast.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, August 21, 2018 ) The Germany over-the-counter (OTC) drugs market has been expected at USD 7.67 billion in 2018 and is projected to reach USD 8.53 billion by using 2023, at a CAGR of 2.15% all through the forecast period from 2018 to 2023. Over-the-counter (OTC) drugs are used to treat situations that do not require direct consultation of a medical doctor. OTC drugs are safe and well tolerated. Those provide low-cost treatment and additionally assist to lower the workload of physicians. The most normally marketing OTC drugs in Germany include Acetaminophen, Aspirin, Ibuprofen, Voltaren Gel, and Dorithricin, among others.

    Request Report Sample: https://www.marketdataforecast.com/market-reports/germany-over-the-counter-drugs-market-800/request-sample

    Rising import of OTC drugs is fuelling the growth of the market
    Factors affecting market growth:
    • Increasing number of chemists & pharma dispensaries (+)
    • Growing trend among individuals to select OTC drugs (+)
    • Escalating health care costs (+)
    • Quick availability (+)
    • Rising import of OTC drugs (+)
    • Strict rules and regulations (-)
    • Availability of other therapies such as homeopathy (-)

    Get your customized report: https://www.marketdataforecast.com/market-reports/germany-over-the-counter-drugs-market-800/customize-report

    Pharmacies/Drug shops segment holds the biggest market share
    Market Segmentation
    The Global over-the-counter (OTC) drugs market is segmented on the basis of
    Product Type
    • Analgesics
    • Cough, Cold and Flu Products
    • Vitamins and Minerals
    • Dermatological Products
    • Gastrointestinal Products
    • Ophthalmic Products
    • Sleep Aid Products
    • Weight Loss/Diet Products
    • Others
    By Formulation Type
    • Tablets
    • Liquids
    • Ointments
    • Sprays
    Distribution Channels
    • Pharmacies
    • Supermarkets/Hypermarkets
    • Convenience stores
    • Others (Online Drug Stores)

    Among all the segments, Pharmacies/Drug shops segment instructions the biggest market share in Germany over-the-counter (OTC) drugs market, by distribution channel in 2016.

    Browse full Table of Contents: https://www.marketdataforecast.com/market-reports/germany-over-the-counter-drugs-market-800/

    Key players:
    The major share holders of the market include Bayer AG (Germany), Johnson & Johnson (U.S.), Almirall S.A. (Spain), GlaxoSmithKline Plc (U.K.), Boehringer Ingelheim GmbH (Germany), PharmaFGP GmbH (Germany), OTC-Pharma Vertrich Gmbh (Germany), Novartis AG (Switzerland), Pfizer AG (Switzerland), and Sanofi S.A. (France).

    Contact Info:
    Name: Mr. Abhishek Shukla
    Email: abhishek@marketdataforecast.com
    Organization: MarketDataForecast™
    Address: 2nd Floor, Above ICICI Bank,B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
    Phone: +1-888-702-9626



    Abhishek Shukla
    +1-888-702-9626
    abhishek@marketdataforecast.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, August 21, 2018 ) The “Global Anesthesia Drugs Analysis to 2025” is a specialized and in-depth study of the Anesthesia Drugs industry with a focus on the global market trend. The report aims to provide an overview of global Anesthesia Drugs with detailed market segmentation by component, wearable, type, application and geography. The global Anesthesia Drugs Software market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

    The List of Companies:

    · Astrazeneca
    · Fresenius-Kabi
    · AbbVie
    · Baxter Healthcare
    · B.Braun
    · Maruishi
    · Piramal
    · Troikaa
    · Claris Life sciences
    · Hikma Pharmaceuticals
    · Mylan
    · Nhwa

    To Grab the SAMPLE or PURCHASE the Full Report please click on the Link @ https://www.qyresearchgroups.com/request-sample/1054782


    Market Size Split by Type

    · Propofol
    · Etomidate
    · Midazolam
    · Sevoflurane
    · Other

    Market Size Split by Application

    · Intravenous Anesthetics
    · Inhalational Anesthetics

    Get the Best Discount Price @ https://www.qyresearchgroups.com/check-discount/1054782

    The report Anesthesia Drugs Market by Manufacturers highlights the essential market dynamics of Anesthesia Drugs sector. The efficiency of this segment has been studied deeply along with the noteworthy challenges and forthcoming growth opportunities and prospective. The report focuses in decision making abilities and supports to make effective counter strategies in order to achieve competitive advantage. Current market scenario of the segment and forecasts of the market situation have also been bounded in this market report.

    Scope of the Report:

    This report focuses on the Global Anesthesia Drugs Market by Manufacturers, Regions, Type and Application, exclusively in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on type, application, regions, and manufacturers.

    Browse full Report @ https://www.qyresearchgroups.com/report/global-anesthesia-drugs-market-insights-forecast-to-2025

    About Us:
    QY Research Groups is a company that simplifies how analysts and decision makers get industry data for their business. Our unique colossal technology has been developed to offer refined search capabilities designed to exploit the long tail of free market research whilst eliminating irrelevant results. QY Research Groups is the collection of market intelligence products and services on the Web. We offer reports and update our collection daily to provide you with instant online access to the world's most complete and current database of expert insights on Global industries, companies, products, and trends.

    Contact us:
    Email- sales@qyresearchgroups.com
    Web- https://www.qyresearchgroups.com


    Zhang Wei
    +1-888-236-2744
    zhang@qyresearchgroups.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, August 21, 2018 ) The report gives the clear picture of current Additive Manufacturing Services Market scenario and the predicted future of the industry. The report focuses on the basis of market drivers, restraints, growth, trends and forecast for the period of 2018-2025. In addition, the report also maps the market performance by value chain analysis which will help in better product differentiation along with the analysis of each segment in terms of opportunity, market attractiveness index and growth rate.

    The report Additive Manufacturing Services Market by Key players highlights the essential market dynamics of Additive Manufacturing Services Market sector. The efficiency of this segment has been studied deeply along with the noteworthy challenges and forthcoming growth opportunities and prospective. The report focuses in decision making abilities and supports to make effective counter strategies in order to achieve competitive advantage. Current market scenario of the segment and forecasts of the market situation have also been bounded in this market report.

    QY Research groups can be relied upon for the most updated and in depth information of the title Global Additive Manufacturing Services Market this is estimated by experts to develop at the most elevated CAGR amid the estimate time frame 2018-2025.

    Get your Sample Report Copy @ https://www.qyresearchgroups.com/request-sample/1031785

    This report focuses on the global top players, covered

    · Arcam AB

    · Stratasys Inc

    · Greatbarch

    · Biomedical Modeling

    · Eos GmbH Electro Optical Systems

    · Envisiontec Gmbh

    · GPI Prototype and Manufacturing Services

    · Morries Technologies

    · Sirona Dental System

    · SLM Solutions GmbH

    · 3D Systems (DDD)

    · ExOne Company

    · ARC Group Worldwide

    · Carbon

    · Cookson Precious Metals


    Market segment by Regions/Countries, this report covers

    · United States

    · Europe

    · China

    · Japan

    · Southeast Asia

    · India


    Market segment by Type, the product can be split into

    · Plastic

    · Metal

    · Rubber

    · Others


    Market segment by Application, split into

    · Automotive Industry

    · Aerospace & Military Industry

    · Chemical Industry

    · Electronic Industry

    · Healthcare & Dental

    · Others

    Get the best Discount in the market here @ https://www.qyresearchgroups.com/check-discount/1031785

    This market is segmented by Types and Applications. It provides a profound study of the leading players in the market and the prevailing regions in the business, thereby benefiting new entries in the business by proving the most updated insights of the market.

    At QY Research Groups we render the most authentic and elaborate information for the utmost benefit of our clients.

    Table of Contents

    Global Additive Manufacturing Services Market Size, Status and Forecast 2025
    1 Industry Overview of Additive Manufacturing Services
    1.1 Additive Manufacturing Services Market Overview
    1.1.1 Additive Manufacturing Services Product Scope
    1.1.2 Market Status and Outlook
    1.2 Global Additive Manufacturing Services Market Size and Analysis by Regions (2013-2018)
    1.2.1 United States
    1.2.2 Europe
    1.2.3 China
    1.2.4 Japan
    1.2.5 Southeast Asia
    1.2.6 India
    1.3 Additive Manufacturing Services Market by Type
    1.3.1 Plastic
    1.3.2 Metal
    1.3.3 Rubber
    1.3.4 Others
    1.4 Additive Manufacturing Services Market by End Users/Application
    1.4.1 Automotive Industry
    1.4.2 Aerospace & Military Industry
    1.4.3 Chemical Industry
    1.4.4 Electronic Industry
    1.4.5 Healthcare & Dental
    1.4.6 Others

    2 Global Additive Manufacturing Services Competition Analysis by Players
    2.1 Additive Manufacturing Services Market Size (Value) by Players (2013-2018)
    2.2 Competitive Status and Trend
    2.2.1 Market Concentration Rate
    2.2.2 Product/Service Differences
    2.2.3 New Entrants
    2.2.4 The Technology Trends in Future

    3 Company (Top Players) Profiles
    3.1 Arcam AB
    3.1.1 Company Profile
    3.1.2 Main Business/Business Overview
    3.1.3 Products, Services and Solutions
    3.1.4 Additive Manufacturing Services Revenue (Million USD) (2013-2018)
    3.2 Stratasys Inc
    3.2.1 Company Profile
    3.2.2 Main Business/Business Overview
    3.2.3 Products, Services and Solutions
    3.2.4 Additive Manufacturing Services Revenue (Million USD) (2013-2018)
    3.3 Greatbarch

    …

    About Us:
    QY Research Groups is a company that simplifies how analysts and decision makers get industry data for their business. Our unique colossal technology has been developed to offer refined search capabilities designed to exploit the long tail of free market research whilst eliminating irrelevant results. QY Research Groups is the collection of market intelligence products and services on the Web. We offer reports and update our collection daily to provide you with instant online access to the world's most complete and current database of expert insights on global industries, companies, products, and trends.


    Zhang Wei
    +1-888-236-2744
    zhang@qyresearchgroups.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, August 21, 2018 ) The report “Global GERD Sales Market by Manufacturers, Regions, Type and Application” highlights key dynamics of GERD Sales sector. The potentiality of this sector has been examined along with the significant challenges and growth opportunities. The present market scenario and future predictions of the sector has also been studied in-depth in this report. The report also provides the key market players that are assessed on numerous parameters such as manufacturer’s summary, revenue generation, product portfolio, and sales analysis of GERD Sales segment in the forecast period. Also, this report involves major market drivers and restraints of the given market.

    The overall market has been experiencing a downturn in terms of revenue in the past several years as the leading drugs for GERD treatment have lost their patent protection, with their market shares now largely consumed by over-the-counter (OTC) and generic medications. Although loss of exclusivity of high-grossing drugs have caused a market fall-off, the demand for acid reducing drugs due to the high prevalence and incidence levels of GERD will prove beneficial to the industry from a commercial standpoint. GERD is one of the commonly observed recurrent gastrointestinal disorders worldwide. The prevalence of acid reflux and related symptoms has increased across the globe by nearly 50% over the last decade. This disorder not only has major effects on the health and quality of patient lives, but also extends to the healthcare system and economy.

    The major manufacturers covered in this report:

    • AstraZeneca
    • Eisai
    • GlaxoSmithKline
    • Johnson & Johnson
    • Takeda
    ...

    For Sample Report with TOC, Please Visit @ https://www.qyresearchgroups.com/request-sample/1040356

    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into:

    • Proton Pumps Inhibitors
    • H2 Receptor Antagonists
    • Antacids
    • Prokinetics

    By Application, the market can be split into

    • Hospital Pharmacy
    • Drug Stores
    • General Stores
    • Supermarkets

    Check Discount @ https://www.qyresearchgroups.com/check-discount/1040356

    The study objectives of this report are:
    • To analyze and study the global GERD sales, value, status (2013-2017) and forecast (2018-2025);
    • To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
    • Focuses on the key GERD players, to study the sales, value, market share and development plans in future.
    • Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
    • To define, describe and forecast the market by type, application and region.
    • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    • To identify significant trends and factors driving or inhibiting the market growth.
    • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
    • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
    • To strategically profile the key players and comprehensively analyze their growth strategies.

    In this study, the years considered to estimate the market size of GERD are as follows:
    • History Year: 2013-2017
    • Base Year: 2017
    • Estimated Year: 2018
    • Forecast Year 2018 to 2025

    Make An Enquiry @ https://www.qyresearchgroups.com/send-an-enquiry/1040356

    About Us:
    QY Research Groups is a company that simplifies how analysts and decision makers get industry data for their business. Our unique colossal technology has been developed to offer refined search capabilities designed to exploit the long tail of free market research whilst eliminating irrelevant results. QY Research Groups is the collection of market intelligence products and services on the Web. We offer reports and update our collection daily to provide you with instant online access to the world's most complete and current database of expert insights on Global industries, companies, products, and trends.

    Contact us:
    Email- sales@qyresearchgroups.com
    Web- https://www.qyresearchgroups.com


    Zhang Wei
    +1-888-236-2744
    zhang@qyresearchgroups.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, August 21, 2018 ) The report also covers the profiles of the key vendors operating in the market covering all the key regions including North America, South America, Europe, APAC and Middle East & Africa. Biomaterials Market| Analysis | Overview | Forecast 2018-2024 evaluates the growth trends of the industry through historical study and helps to gain a competitive edge and potential customer in the market. Moreover, this report also helps to understand the knowledge of industry structure and as we look into our analysis of key market developments, we can confidently state that the market behaviour is as per our forecast trajectory backed by recent market developments.

    Request free sample report https://www.envisioninteligence.com/industry-report/biomaterials-market/?utm_source=ew-bipin

    This report will assist in the following arenas:

    • Streamlining the product offerings by analyzing the competitor product portfolio, financials and their developmental relationships with other associated companies and this could help you in sustaining in competitive environment and business expansion prospects.

    • Additionally, regional and technological trends which are included in the report will support in comprehending the market dynamics and information on promising locations/areas with target audience information to intensify sales and business outreach.

    • Identifying the problem areas in your business and in recognizing new business opportunities, changing market dynamics and to minimize the risks associated in the emerging market areas

    Key Topics Covered

    1. Introduction
    2. Research Methodology
    3. Market Analysis
    4. Market Dynamics
    5. Biomaterial Market – By Specialty
    6. Biomaterial Market – By Type of Material
    7. Biomaterial Market – By Geography
    8. Biomaterial Market – Company Profiles
    9. Biomaterial Market – Competitive Landscape
    10. Market Insights
    11. Appendix

    Key Players:

    • Celsense Corporation
    • DuPont
    • Biomet, Inc.
    • Zimmer Biomet Holdings, Inc.
    • Wright Medical Group, Inc.
    • Invibio Ltd.


    Prefabricated Buildings Market – By Geography

    • Introduction
    • North America
    • The U.S.
    • Canada
    • Mexico
    • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia & New Zealand
    • Rest of APAC
    • South America
    • Brazil
    • Argentina
    • Others
    • Middle East & Africa
    • The Middle East
    • Africa

    Related Titles

    Middle East & Africa Biomaterials Market:https://www.envisioninteligence.com/industry-report/middle-east-africa-biomaterials-market/?utm_source=ew-bipin


    South America Biomaterials Market:https://www.envisioninteligence.com/industry-report/south-america-biomaterials-market/?utm_source=ew-bipin


    North America Biomaterials Market;https://www.envisioninteligence.com/industry-report/north-america-biomaterials-market/?utm_source=ew-bipin

    About us:
    Envision Inteligence is the Main Supplier of Market Analysis Reviews, Customized Consulting for Companies, Information Analytics and Trade Evaluation. Our purpose is to offer the correct data required by the stakeholder on the proper level of time, in a format which assists a clever and knowledgeable resolution making a course of!

    Contact us:
    Sales Team,
    Sales@envisioninteligence.com
    Call: +1 408-963-0099
    Web: www.envisioninteligence.com


    Bharadwaj Oruganti
    1-408-963-0099
    bharadwaj@envisioninteligence.com

    Source: EmailWire.Com

older | 1 | .... | 1068 | 1069 | (Page 1070) | 1071 | 1072 | .... | 1118 | newer